VA prescott lenalidomide do

Active Awarded Last action

Contract number
36C26226N0310
Awardee
Awarding agency
Obligated
$1,822,085

Award facts

Contract value 100% obligated
$1,822,085.00 Current and potential, with all options
Completion date 77% complete
Current and potential, with all options
Contracting staff
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Boca Raton, FL 33432, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · VA prescott lenalidomide do MOD updating pricing $0

About this award

The Department of Veterans Affairs Veterans Integrated Service Network 22 issued a BPA call to Exelan Pharmaceuticals Inc. on January 15, 2026, for Lenalidomide pharmaceutical supply with a ceiling value of $1,822,085, with final completion scheduled for January 14, 2027.

The call is issued under the VA VISN 22 Lenalidomide BPA, a $21.17 million blanket purchase agreement that provides framework pricing for Lenalidomide products to support oncology and hematologic malignancy treatment protocols across the Veterans Integrated Service Network. Performance occurs in Boca Raton, Florida. Exelan is a pharmaceutical manufacturing and repackaging specialist serving federal healthcare systems including the VA, DoD, Bureau of Prisons, and Indian Health Service, competing on an unrestricted basis without set-aside designation. The firm maintains active SAM registration and operates primarily as a prime contractor performing substantially all work at its Boca Raton facility.

Quick answers

Who was awarded contract 36C26226N0310?

36C26226N0310 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on January 15, 2026.

How much is contract 36C26226N0310 worth?

The government has obligated $1,822,085 on 36C26226N0310.

Is contract 36C26226N0310 an order under another contract?

Yes. 36C26226N0310 is a BPA call under 36F79720D0227-36C26226A0006, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26226N0310 competed?

The extent of competition for 36C26226N0310 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award